Skip to main content
Equibles

TORONTO DOMINION BANK

Bank

Position in RARE — Ultragenyx Pharmaceutical Inc.

CIK 947263 TORONTO, ONTARIO, A6
Back to RARE Full portfolio

Position in RARE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$13,856,850
+$13,853,457 QoQ
Shares Held
415,000
+256072.8% QoQ
Ownership
0.421%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#46
of 311 holders
Holding Since
Mar 2020
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RARE Over Time

Shares Held

Position Value (USD)

Derivatives in RARE

reported options exposure · as of Dec 31, 2025
CallValue
$632,500
CallShares
27,500
PutValue
$862,500
PutShares
37,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TORONTO DOMINION BANK holds $769,395,513 across 60 Biotechnology names. RARE ranks #11 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PTCT
Ptc Therapeutics, Inc.
 2,165,846 $176,668,057
2 CELC
Celcuity Inc.
 1,258,758 $131,691,261
3 STOK
Stoke Therapeutics, Inc.
 3,173,258 $103,829,001
4 MDGL
Madrigal Pharmaceuticals, Inc.
 181,432 $97,419,912
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 85,391 $42,416,270
6 TARS
Tarsus Pharmaceuticals, Inc.
 510,253 $32,115,323
7 REGN
Regeneron Pharmaceuticals, Inc.
 48,783 $30,418,151
8 NGNE
Neurogene Inc.
 681,337 $21,428,048

All Filings in RARE

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $13,856,850 415,000
2026-03-31 $3,393 162
2025-12-31 $862,500 37,500
2025-12-31 $632,500 27,500
2025-12-31 $729,100 31,700
2022-09-30 $815,777 19,700
2020-03-31 $1,332 30